BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Oppenheimer
February 22, 2019 7:47 AM
Oppenheimer analyst Leland Gershell lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $81.00 (from $92.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
